New cancer clinical trial: A Phase III Study of CS1001 in Subject With Stage IV Non-Small Cell Lung Cancer

Published on: December 28, 2018 at 12:00PM
Condition:   Non Small Cell Lung Cancer
Interventions:   Biological: CS1001 monoclonal antibody;   Biological: CS1001 placebo
Sponsor:   CStone Pharmaceuticals
Recruiting
http://bit.ly/2SwvwWF